Stocks Screener

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

AlzeCure Pharma

ALZCUR
Current price
2 SEK +0.015 SEK (+0.76%)
Last closed 1.98 SEK
ISIN SE0010133785
Sector Healthcare
Industry Biotechnology
Exchange Stockholm Exchange
Capitalization 173 954 390 SEK
Yield for 12 month -48.85 %
1Y
3Y
5Y
10Y
15Y
ALZCUR
21.11.2021 - 28.11.2021

AlzeCure Pharma AB (publ), a pharmaceutical company, develops drug therapies for the treatment of severe diseases and conditions that affect the central nervous system. The company is involved in the development of drug candidates based on the NeuroRestore, Alzstatin, and Painless research platforms. Its products pipeline includes ACD856 for the treatment of Alzheimer's disease, sleep disorders, depression, traumatic brain injuries, and Parkinson's disease, which is in phase I clinical trial; ACD857, ACD679, and ACD680 that are in preclinical trial for the treatment of Alzheimer's disease; ACD440, a TRPV1 antagonist that has completed phase I clinical trial for neuropathic pain indications; and ACD137, negative allosteric modulator (NAM) of TrkA receptors for osteoarthritic pain indications. AlzeCure Pharma AB (publ) was founded in 2012 and is based in Huddinge, Sweden. Address: Hälsovägen 7, Huddinge, Sweden, 141 57

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

101.84 SEK

P/E ratio

Dividend Yield

Current Year

Last Year

Current Quarter

Last Quarter

Current Year

-473 634 SEK

Last Year

-567 163 SEK

Current Quarter

-68 660 SEK

Last Quarter

-108 459 SEK

Key Figures ALZCUR

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA -36 270 582 SEK
Operating Margin TTM
PE Ratio
Return On Assets TTM -48.29 %
PEG Ratio
Return On Equity TTM -89.05 %
Wall Street Target Price 101.84 SEK
Revenue TTM -73 632 SEK
Book Value 0.45 SEK
Revenue Per Share TTM
Dividend Share
Quarterly Revenue Growth YOY
Dividend Yield
Gross Profit TTM
Earnings per share -0.49 SEK
Diluted Eps TTM -0.49 SEK
Most Recent Quarter II 2024
Quarterly Earnings Growth YOY
Profit Margin

Dividend Analytics ALZCUR

Dividend growth over 5 years

Continuous growth

Payout Ratio 5 years average

Dividend History ALZCUR

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
Ex Dividend Date
Forward Annual Dividend Yield
Last Split Factor
Payout Ratio
Last Split Date
Dividend Date

Stock Valuation ALZCUR

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
Forward PE
Enterprise Value Revenue
Price Sales TTM
Enterprise Value EBITDA -3.1754
Price Book MRQ 4.3392

Financials ALZCUR

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators ALZCUR

For 52 weeks

1.59 SEK 4.77 SEK
50 Day MA 1.95 SEK
Shares Short Prior Month
200 Day MA 2.36 SEK
Short Ratio
Shares Short
Short Percent